-
Joel A, Abhilash KP, Anandan S, Veeraraghavan B, Rupali P. Listeria Meningitis with Disseminated Tuberculosis in a HIV Positive Individual. J Glob Infect Dis. 2013 Jan;5(1):34-5. doi: 10.4103/0974-777X.107175. PMID: 23599618; PMCID: PMC3628234.
-
Joel A, Mathew N, Andugala SS, Daniel S, Gnanamuthu BR, John AO, Georgy JT, Chacko RT, Irodi A, Yadav B, John S, Singh A. Primary mediastinal germ cell tumours: real world experience in the low middle income (LMIC) setting. Ecancermedicalscience. 2021 Feb 11;15:1186. doi: 10.3332/ecancer.2021.1186. PMID: 33777179; PMCID: PMC7987494. Link
-
Joel A, Georgy JT, Thumaty DB, John AO, Chacko RT, Rebekah G, Sigamani E, Chandramohan J, Manipadam MT, Cherian AJ, Abraham DT, Jacob PM, Sebastian P, Backianathan S, Singh A. Neoadjuvant chemotherapy with biosimilar trastuzumab in human epidermal growth factor receptor 2 overexpressed non-metastatic breast cancer: patterns of use and clinical outcomes in India. Ecancermedicalscience. 2021 Mar 19;15:1207. doi: 10.3332/ecancer.2021.1207. PMID: 33912232; PMCID: PMC8057782.
-
Chandramohan, Anuradha, Panda, Sourav, Thomas, Anitha, Chandy, Rachel, Joel, Anjana, Ram, Thomas Samuel and Peedicayil, Abraham Management Driven Structured Reporting in Ovarian Cancer Journal of Gastrointestinal and Abdominal Radiology; 2020, 03 (02): 153-162 DOI: 10.1055/s-0039-1698480
-
Oommen I, Chandramohan A, Raji PS, Thomas A, Joel A, Samuel Ram T, Peedicayil A. Clinical significance of CT detected enlarged cardiophrenic nodes in ovarian cancer patients. Abdom Radiol (NY). 2021 Jan;46(1):331-340. doi: 10.1007/s00261-020-02618-z. PMID: 32577780.
-
Farooq M, Daniel S, Joel A, Thampi John N. Successful management of small cell neuroendocrine carcinoma of the ureter with neoadjuvant chemotherapy and adjuvant chemoradiation: case report and literature review. BMJ Case Rep. 2021 Aug 17;14(8):e240613. doi: 10.1136/bcr-2020-240613. PMID: 34404642; PMCID: PMC8375734.
-
Krishnamoorthy A, Joel A, Abhilash KP. Cryptococcal Meningitis with Multiple Cranial Nerves Palsies: A Review of Literature. J Glob Infect Dis. 2015 Jul-Sep;7(3):123-4. doi: 10.4103/0974-777X.161739. PMID: 26392724; PMCID: PMC4557145.
-
Krishnamoorthy A, Joel A, Abhilash KP. Cryptococcal Meningitis with Multiple Cranial Nerves Palsies: A Review of Literature. J Glob Infect Dis. 2015 Jul-Sep;7(3):123-4. doi: 10.4103/0974-777X.161739. PMID: 26392724; PMCID: PMC4557145.
-
Prineethi S, Irodi A, Eapen A, Milton S, Joel A. Growing Teratoma Syndrome-A Clinicoradiological Series. Indian J Radiol Imaging. 2022 Aug 17;32(3):301-307. doi: 10.1055/s-0042-1744519. PMID: 36177285; PMCID: PMC9514900.
-
Sharma P, Georgy JT, Andrews AG, John AO, Joel A, Chacko RT, Premkumar PS, Singh A. Anemia requiring transfusion in breast cancer patients on dose-dense chemotherapy: Prevalence, risk factors, cost and effect on disease outcome. Support Care Cancer. 2022 Mar 21:1โ8. doi: 10.1007/s00520-022-06970-2. Epub ahead of print. PMID: 35314996; PMCID: PMC8937495.
-
Agrawal, M., Konduru, V., Riju, J., Singh, A., Joel, A., Karuppusami, R. and Tirkey, A. J. Definitive Surgery after Neoadjuvant Chemotherapy for Locally Advanced Oral Cavity Cancers: Experience from a Tertiary Care Center South Asian Journal of Cancer; 2023, 01:1-92, e1 Link
-
Arora S, Joel A. Pancreatic cancer in a case of idiopathic chronic pancreatitis. Indian J Med Res. 2013 Oct;138(4):568. PMID: 24434269; PMCID: PMC3868077.
-
Georgy JT, Singh A, John AO, Joel A, Andrews AG, Thumaty DB, Rebekah G, Sigamani E, Chandramohan J, Manipadam MT, Cherian AJ, Abraham DT, Paul MJ, Balakrishnan R, Backianathan S, Chacko RT. Pathological response and clinical outcomes in operable triple-negative breast cancer with cisplatin added to standard neoadjuvant chemotherapy. Klin Onkol. 2021 Winter;34(1):49-55. English. doi: 10.48095/ccko202149. PMID: 33657819.
-
Joel A, Mathew N, Andugala SS, Daniel S, Gnanamuthu BR, John AO, Georgy JT, Chacko RT, Irodi A, Yadav B, John S, Singh A. Primary mediastinal germ cell tumours: real world experience in the low middle income (LMIC) setting. Ecancermedicalscience. 2021 Feb 11;15:1186. doi: 10.3332/ecancer.2021.1186. PMID: 33777179; PMCID: PMC7987494.
-
Singh A, Thomas Georgy J, Dhananjayan S, Sigamani E, Oommen John A, Joel A, Chandramohan J, Abarna R, Rebekah G, Backianathan S, Thomas Abraham D, Jacob Paul M, Titus Chacko R, Therese Manipadam M, Pai R. Comparative Analysis of Mutational Patterns in Triple Negative Breast Cancer Before and after Neoadjuvant Chemotherapy in Patients with Residual Disease. Gene. 2023 Nov 9:147980. doi: 10.1016/j.gene.2023.147980. Epub ahead of print. PMID: 37951371.
-
Nikita Mehra, Prasanth Ganesan, Jayachandran P K, Anjana Joel, Parathan Karunakaran, Venkatraman Radhakrishnan, Trivadi S. Ganesan, Krishna Rathinam, and Sagar Tenali Gnana Phase II trial of GVDexa (gemcitabine, vinorelbine and dexamethasone) regimen in relapsed/refractory Hodgkinโs lymphoma. Journal of Clinical Oncology 2021 39:15_suppl, e19519-e19519 Link
-
Thumaty DB, Chacko RT, John AO, Joel A, Georgy JT, Jacob M, Samarasam I, Masih D, Isaiah R, Jeyaseelan V, Singh A. Docetaxel, Oxaliplatin and Capecitabine (TEX) triplet regimen as adjuvant chemotherapy in resected gastric adenocarcinoma. Ecancermedicalscience. 2021 Sep 21;15:1292. doi: 10.3332/ecancer.2021.1292. PMID: 34824615; PMCID: PMC8580596.
-
Das A, Surendran S, Mathew M, Irodi A, Singh A, Joel A, Yacob M, Isiah R, Samarasam I, John S, Pavamani S, Sasidharan BK. Patterns of Recurrence in Locally Advanced Resectable Oesophageal Carcinoma: Retrospective Review from a Tertiary Cancer Centre in South India. J Gastrointest Cancer. 2021 Jun;52(2):711-718. doi: 10.1007/s12029-020-00464-2. PMID: 32720121.
-
Joel A, Carey RA, Rajadoss JV, Chacko RT. Numb chin syndrome as a manifestation of non-small cell lung cancer. South Asian J Cancer. 2013 Oct;2(4):219. doi: 10.4103/2278-330X.119919. PMID: 24455638; PMCID: PMC3889041.
-
Sharma P, Georgy JT, Andrews AG, John AO, Joel A, Chacko RT, Premkumar PS, Singh A. Anemia requiring transfusion in breast cancer patients on dose-dense chemotherapy: Prevalence, risk factors, cost and effect on disease outcome. Support Care Cancer. 2022 Jun;30(6):5519-5526. doi: 10.1007/s00520-022-06970-2. Epub 2022 Mar 21. PMID: 35314996; PMCID: PMC8937495.
-
Jose N, Joel A, Selvakumar RJ, Ramireddy J, John AO, Georgy JT, Singh A, Ram TS. Diagnosis and management of 5-fluorouracil (5-FU)-induced acute leukoencephalopathy: lessons learnt from a single-Centre case series. J Egypt Natl Canc Inst. 2022 May 23;34(1):22. doi: 10.1186/s43046-022-00117-4. PMID: 35599280.
-
John AO, Singh A, Bala D, Joel A, Georgy JT, Jesudasan MR, Mittal R, Ram TS, Reddy JR, Murthy A, Chandramohan A, Eapen A, Masih D, Ramnath N, Dobrosotskaya I, Yadav B, Chacko RT. Total Neoadjuvant Therapy (TNT) with Full Dose Concurrent Chemotherapy in Locally Advanced Rectal Adenocarcinoma Including Signet Ring and Mucinous Cancers. J Gastrointest Cancer. 2023 Jul 21. doi: 10.1007/s12029-023-00941-4. Epub ahead of print. PMID: 37479897.
-
Joel A, Singh A, Hepzibah J, Devasia A, Kumar S, Gnanamuthu BR, Chandramohan A, George AJP, John NT, Yadav B, John AO, Georgy JT, John S, Chacko RT. End-of-Treatment FDG PET-CT (EOT-PET) in Patients with Post-Chemotherapy Masses for Seminoma: Can We Avoid Further Intervention? South Asian J Cancer. 2022 Aug 22;11(4):315-321. doi: 10.1055/s-0041-1735480. PMID: 36756102; PMCID: PMC9902077.
-
Sivamani P, Eriyat V, Mathew SK, Singh A, Aaron R, Chacko RT, Joel A, Prabha R, Mathew BS. Identification of DPYD variants and estimation of uracil and dihydrouracil in a healthy Indian population. Per Med. 2023 Jan;20(1):39-53. doi: 10.2217/pme-2022-0042. Epub 2022 Nov 23. PMID: 36416570.
-
Mathew N, Joel A, Andrews AG, John AO, Singh A. CDK 4/6 inhibitor induced lung injury: a case report and review of literature. Ecancermedicalscience. 2021 Jun 7;15:1245. doi: 10.3332/ecancer.2021.1245. PMID: 34267801; PMCID: PMC8241445.
-
Bhatt AD, Joel A, Chacko R. Lesser known evil of a commonly used devil-bleomycin induced flagellate dermatitis. Indian Dermatol Online J. 2014 Oct;5(4):517. doi: 10.4103/2229-5178.142530. PMID: 25396145; PMCID: PMC4228657.
-
Chandy RG, Thomas V, Sebastian A, Mani T, Thomas A, Joel A, Ram TS, Peedicayil A. Survival outcomes of epithelial ovarian cancer treated at a tertiary-level hospital in India. Indian J Cancer. 2023 Oct 1;60(4):475-485. doi: 10.4103/ijc.IJC_496_20. Epub 2024 Jan 3. PMID: 38185864.
-
Singh A, Georgy JT, Joel A, Thumaty DB, John AO, Ramnath N, George TK, Sharma P, Patole S, Rebekah G, Sigamani E, Manipadam MT, Cherian AJ, Abraham DT, Paul MJ, Balakrishnan R, Sebastian P, Backianathan S, Chacko RT. Dose-Dense Docetaxel-Cyclophosphamide and Epirubicin-Cisplatin(ddDCEP): Analysis of an Alternative Platinum-Containing Regimen in 116 Patients with Early Triple Negative Breast Cancer. Cancer Invest. 2023 Oct;41(9):789-802. doi: 10.1080/07357907.2023.2278048. Epub 2023 Nov 17. PMID: 37909664.
-
Godfred AC, Thomas Z, Peter D, Joseph A, Ravichandran L, George AA, Pulimood SA, Gaikwad P, Babu R, Thomas M, Thomas N, Chapla A. A Novel Large Deletion in the EVER1 Gene in a Family With Epidermodysplasia Verruciformis From India. Am J Dermatopathol. 2024 Apr 4. doi: 10.1097/DAD.0000000000002657. Epub ahead of print. PMID: 38574087.
-
Shah MN, Thomas V, Joel A, Karuppusami R, Thomas DS, Sebastian A, Thomas A, Chandy R, Peedicayil A. Sex cord ovarian tumours over 10 years: a retrospective analysis of clinicopathological profile and outcome. Ecancermedicalscience. 2024 Sep 16;18:1769. doi: 10.3332/ecancer.2024.1769. PMID: 39430077; PMCID: PMC11489093. Link
-
Sebastian R, Georgy JT, George A, Santhanam P, Philip R, Joel A, John AO, Philip DSJ, Thumaty DB, Kodiatte TA, Singh A, Pai R. Real world outcomes with Tepotinib in a series of Indian patients with MET exon 14 skipping positive non-small cell lung cancer. Ecancermedicalscience. 2025 Aug 15;19:1966. doi: 10.3332/ecancer.2025.1966. PMID: 41333367; PMCID: PMC12665903.
-
Georgy JT, Regi SS, Georgy RV, Sasidharan BK, Joel A, Philip DSJ, John AO, Thumaty DB, Marimuthu PK, Jambunathan P, Harikrishna K, Thomas Z, Rani NJ, Tirkey AJ, Thomas M, Isiah R, Singh A. Low-dose nivolumab plus induction chemotherapy for locally advanced or unresectable head and neck cancer is associated with high response rates and conversion to definitive therapy. Sci Rep. 2025 Oct 8;15(1):35110. doi: 10.1038/s41598-025-19197-y. PMID: 41062634; PMCID: PMC12508025.
-
Marimuthu PK, Georgy JT, Philip DSJ, John AO, Joel A, Thumaty DB, Chacko RT, Jambunathan P, Thomas Z, Harikrishna K, Isiah R, Pavamani SP, Sasidharan B, Mathew M, Alex Kodiatte T, Irodi A, Thangakunam B, Isaac BTJ, Gupta R, Rani J, Singh A. Real-World Outcomes of Induction Chemotherapy With or Without Low-Dose Nivolumab for Stage III Non-Small Cell Lung Cancer Ineligible for Up-Front Local Therapy: A Propensity Score-Matched Analysis. JCO Glob Oncol. 2025 Mar;11:e2400256. doi: 10.1200/GO-24-00256. Epub 2025 Mar 24. PMID: 40127380.
-
Jeslin A.G., Natarajan S., Hiriyanna S., Ninan R., Cecil G.H., Simon B., Eapen A., Thomas V., Thomas A., Varghese K.M., Joel A., Singh A., Karuppusami R., Chandramohan A. (2026) A decision-support tool for management of advanced epithelial ovarian cancer in a single centre in India (CT PAUSE Nomogram): a prospective Study (2022โ2024). The Lancet Regional Health - Southeast Asia 49. DOI: 10.1016/j.lansea.2026.100768.